In-Depth Review of Familial Dyslipidemias Type III: Dysbetalipoproteinemia - A Q&A Format

Описание: https://usmleqa.com/?p=27800
Question: What is Familial Dyslipidemias?
Answer: Familial Dyslipidemias is a type of genetic disorder that affects lipid metabolism.Question: What type of Familial Dyslipidemias is being discussed in the text?
Answer: The text is discussing Familial Dyslipidemias Type III, also known as Dysbetalipoproteinemia.Question: How is Dysbetalipoproteinemia inherited?
Answer: Dysbetalipoproteinemia is inherited in an autosomal dominant manner.Question: What causes Dysbetalipoproteinemia?
Answer: Dysbetalipoproteinemia is caused by a defective apolipoprotein E (ApoE) in type III.Question: What are the increased blood levels seen in Dysbetalipoproteinemia?
Answer: In Dysbetalipoproteinemia, there are increased blood levels of chylomicrons and very low-density lipoproteins (VLDL).Question: What are the clinical features of Dysbetalipoproteinemia?
Answer: The clinical features of Dysbetalipoproteinemia include premature atherosclerosis, tuberoeruptive and palmar xanthomas. Question: Can you explain what "premature atherosclerosis" means?
Answer: Premature atherosclerosis refers to the development of fatty deposits (atheromas) in the arteries at an earlier age than expected.Question: What are "tuberoeruptive xanthomas"?
Answer: Tuberoeruptive xanthomas are raised yellowish growths on the skin that occur as a result of lipid deposits.Question: What are "palmar xanthomas"?
Answer: Palmar xanthomas are yellowish-orange patches that develop on the palms of the hands and are caused by lipid deposits.Question: What is the significance of apolipoprotein E (ApoE)?
Answer: Apolipoprotein E (ApoE) plays a crucial role in lipid metabolism and is defective in type III of Familial Dyslipidemias.Question: What is the difference between chylomicrons and VLDL?
Answer: Chylomicrons are lipoprotein particles that transport dietary lipids from the small intestine to the rest of the body, while very low-density lipoproteins (VLDL) are lipoprotein particles that transport excess triacylglycerols from the liver to other tissues. Question: How does dysbetalipoproteinemia affect lipid metabolism?
Answer: In dysbetalipoproteinemia, there is a defect in the apolipoprotein E (ApoE) leading to an abnormal lipid metabolism and an increase in blood levels of chylomicrons and VLDL.Question: What is the relationship between dysbetalipoproteinemia and xanthomas?
Answer: Dysbetalipoproteinemia can lead to the development of xanthomas, which are raised yellowish growths on the skin caused by lipid deposits.Question: What is the relationship between dysbetalipoproteinemia and atherosclerosis?
Answer: Dysbetalipoproteinemia can lead to the development of premature atherosclerosis, which is the formation of fatty deposits in the arteries at an earlier age than expected.Question: Can dysbetalipoproteinemia be treated?
Answer: Yes, dysbetalipoproteinemia can be treated with dietary changes, lifestyle modifications, and medications to lower lipid levels and prevent the progression of the disease.Question: Is dysbetalipoproteinemia a common condition?
Answer: Dysbetalipoproteinemia is a relatively uncommon condition and is estimated to affect 1 in 1,000 to 2,500 people.tab